| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Seres Therapeutics, Inc. (MCRB) have been net sellers, shedding 490 shares worth roughly $2K on balance.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 12.5K | $24.5K | - | |
| Other | 8.7K | $17.0K | - | |
| Other | 8.6K | $16.8K | - | |
| Other | 8.1K | $15.9K | - | |
| Other | 8.0K | $15.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 6, 2018 | Roger Pomerantz | President and CEO | Sell | 12,518 | $9.10 | $113,949.53 | -5.5% | |
| Jul 15, 2018 | John G. Aunins | Chief Technology Officer & EVP | Sell | 14,279 | $8.10 | $115,725.58 | -8.1% | |
| Jul 11, 2018 | Roger Pomerantz | President and CEO | Sale+OE | 1,010 | $9.01 | $9,098.99 | -0.4% | |
| Jul 10, 2018 | Roger Pomerantz | President and CEO | Sale+OE | 32,336 | $9.12 | $295,065.31 | -12.4% | |
| Jun 29, 2018 | Roger Pomerantz | President and CEO | Sale+OE | 26,056 | $9.15 | $238,290.73 | -10.2% | |
| Jun 27, 2018 | Roger Pomerantz | President and CEO | Sale+OE | 64,967 | $9.16 | $595,045.43 | -22.2% | |
| Jun 22, 2018 | Roger Pomerantz | President and CEO | Sell | 85,536 | $9.28 | $793,906.79 | -26.4% | |
| Jun 15, 2018 | John G. Aunins | Chief Technology Officer & EVP | Sell | 14,279 | $8.57 | $122,325.34 | -7.7% | |
| May 9, 2018 | Roger Pomerantz | President and CEO | Sell | 233 | $9.00 | $2,097.00 | - | |
| Apr 25, 2018 | John G. Aunins | Chief Technology Officer & EVP | Sell | 14,279 | $7.58 | $108,266.23 | -7.2% |